But Arsenal has been flying high. The company’s Series B funding round in 2022 brought in $220 million, and its Series C last ...

A recent survey of 802 people ages 18 to 24 suggests that Gen Z is proscience, with 91 percent of respondents saying they ...

Local companies have shut down or scaled back in the industry’s decline, threatening scientific progress on cancer, ...

The prospects of higher pay, regular hours, comprehensive benefits, and career growth has workers filling biotech training ...

Bluebird bio has re-emerged after a private equity buyout as Genetix Biotherapeutics, marking a return to its roots and a new ...

For our methodology, we first screened biotech stocks trading below $5 per share and showing positive year-to-date (YTD) ...

Luxa Biotechnology LLC announced results from its phase 1/2a clinical trial titled “Safety and Tolerability of RPE Stem ...

Here is our list of the top 10 AI-powered biotech stocks to buy now.

Thousand Oaks-based biotech giant Amgen Inc. announced this month that it plans to invest more than $600 million in a new, ...

Are pharma companies pulling their money out of the U.K. because of Trump? And how is biotech M&A pacing this year?

Talented people are losing their jobs, postdoctoral researchers are seeing contracts cut short and students are rushing to ...

A Chinese biotech firm has skyrocketed more than 4,500% in the three months since its Hong Kong debut, stoking worries of ...